ANALYST VIEW - Goldman Sachs upgrades Hungary's Richter

Hungary Richter reports robust performance for Q4 2016

Profit doubled, yet share price is falling.

Hungary Richter may be thankful to Russia

Analysts expect major profit growth for Q416.

ANALYST VIEW - J.P. Morgan ups target price for Hungary's Richter

Hungary Richter inks distribution & supply deal with Allergan

Levosert goes to Europe.

Hungary’s Richter announces positive Phase III results for new drug

Hungary Richter CEO says they must be "much more aggressive"

In female healthcare product acquistions.

Hungary 2016 Top Stories: Budapest Stock Exchange at all-time high

Finally exceeding 2007 level.

Hungarian pharma Richter withdraws pegfilgrastim marketing application

Negotiating the curves of the biosimilar scene.

Changes in Executive Board and Board of Directors at Hungary's Richter

Hungary Richter delivers good news again

ANALYST VIEW - Jefferies sharply raises target price for Hungary's Richter

The rating is 'Buy'.

ANALYST VIEW - HSBC ups target price for Hungary's Richter by 11%

Hungary Richter has greatly improved expectations for 2016

Brighter hopes for Russia.

Hungary's Richter beats Q3 expectations, one-offs help

Profit guidance raised for 2016.

Hungary Richter Q3 profit seen up sharply from low base

80% growth seen in net profit.

Hungary Richter inks deal for exclusive distribution of DM Bio product

Hungary Richter to step up its Russian game

Hungary Richter appoints former state secretary as new strategy chief

Bad news from Hungary's Richter on cariprazine effect